PROTECT VIII kids extension study: Long-term safety and efficacy of BAY 94-9027 (damoctocog alfa pegol) in children with severe haemophilia A.

Maria Elisa MancusoTina BissKathelijn FischerMonika Maas EnriquezMacGregor SteeleMaria WangDespina Tseneklidou-StoeterSanjay AhujaGili Kenet

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)

BAY 94-9027 showed long-term safety and efficacy for the prevention and treatment of bleeds in younger and older paediatric patients with severe haemophilia A.

Keyphrases

early onset
emergency department
intensive care unit
young adults
physical activity
replacement therapy
drug induced
middle aged
water quality